Friday 6 November 2026 Export PEN’s income statement to Excel — free account

Penumbra, Inc.

PEN Healthcare Medical Devices

Penumbra, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 17.5% from fiscal 2024.

Revenue: +15.6%
EPS: −8.29%
Free cash flow: −37.2%
Total debt: −10.3%

Quarter to September 2026, against a year earlier

319.62 1.49 −0.46%

Follow PEN

Alert me

Market cap: $12.7B
P/E: 80.3×
Fwd P/E: 68.7×
Dividend yield: —
F-score: 8/9
Altman Z: 20.17
Beneish M: −2.48
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Penumbra, Inc. (PEN) P/E ratio

Alert me on P/E ratio

As of 5 November 2026, Penumbra, Inc. (PEN) trades at a P/E ratio of 80.3×. Over the past ten years it has ranged from 0.0× (March 2023) to 2,127× (June 2023); the current reading is higher than 41% of that period. That is above the Medical Devices industry median of 25.6× and above the Healthcare sector median of 25.2×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/PEN/pe-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Penumbra, Inc. P/E ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/PEN/metrics/pe-ratio">Penumbra, Inc. (PEN) P/E ratio — stockrow.com</a></p>

Period	P/E ratio	Change
FY2025	68.0×	(89.40%)
FY2024	642×	516.22%
FY2023	104×	—
FY2022	0.0×	—
FY2021	1,915×	—
FY2020	0.0×	—
FY2019	117×	(81.76%)
FY2018	643×	(9.52%)
FY2017	711×	438.39%
FY2016	132×	—

Period	P/E ratio	Change
Sep 2026	79.7×	3.27%
Jun 2026	77.2×	2.97%
Mar 2026	75.0×	10.20%
Dec 2025	68.0×	13.87%
43 more quarters	Free account

Against its own ten years

Low 0.0× High 2,127×

Ten-year median 126×

Current reading's percentile 17

Company	P/E ratio
BRKR Bruker Corporation compare	n/m
GKOS Glaukos Corporation compare	n/m
TXG 10x Genomics compare	n/m
BIO Bio-Rad Laboratories, Inc. compare	9.7×
BIO.B Bio-Rad Laboratories, Inc. compare	9.9×
GMED Globus Medical, Inc. compare	19.5×
PODD Insulet Corporation compare	25.2×
SNN Smith & Nephew SNATS, Inc. compare	38.9×
PEN Penumbra, Inc.	80.3×
Medical Devices industry median	25.6×
Healthcare sector median	25.2×
Market median	17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

Penumbra, Inc. (PEN) P/E ratio

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on PEN

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on PEN

Stockrow Weekly